Abstract
Tyrosinase is a multi-copper enzyme widely distributed in different organisms, including plants & mammals, etc., which is responsible for pigmentations, undesired browning of fruits and vegetables. This is the key enzyme in the melanogenesis in human and molting process of insects. Therefore the inhibitors of the enzyme may lead to novel skin whitening agents, anti-browning substances or compounds for insect control. A large numbers of moderate to potent tyrosinase inhibitors have been reported during the last decade. From our group, we reported a number of potent inhibitors from synthetic, semi-synthetic and natural origins. The compounds are from several chemical classes, like phenolics, terpenes, steroids, chalcones, flavonoids, alkaloids, long-chain fatty acids, coumarins, sildenafil analogs, bipiperidines, biscoumarins, oxadiazole, tetraketones, etc. More recently, the crystal structure of mushroom and couple of other tyrosinases has been published and more recently the crystal structure of mushroom tyrosinase complexes with a highly potent inhibitor tropolone has been reported. Yet there is a lack of information of inhibitor-tyrosinase intermolecular interactions. To overcome such issues, some researchers started utilizing in silico tools, like molecular docking simulations, for such purposes. There are also few papers published about the successful utilization of computational tools like QSAR-based and ligand-based virtual screening to identify novel and potent inhibitors of the enzyme. In our group, we are using all possible computational tools, like ligand-based as well structure-based approaches, to identify new inhibitors. In this review, some of such examples are briefly described.
Keywords: Mushroom tyrosinase, tyrosinase inhibitors, molecular docking, QSAR, 3D-QSAR, CoMFA, CoMSIA
Current Medicinal Chemistry
Title:Novel Tyrosinase Inhibitors From Natural Resources – Their Computational Studies
Volume: 19 Issue: 14
Author(s): M.T.H. Khan
Affiliation:
Keywords: Mushroom tyrosinase, tyrosinase inhibitors, molecular docking, QSAR, 3D-QSAR, CoMFA, CoMSIA
Abstract: Tyrosinase is a multi-copper enzyme widely distributed in different organisms, including plants & mammals, etc., which is responsible for pigmentations, undesired browning of fruits and vegetables. This is the key enzyme in the melanogenesis in human and molting process of insects. Therefore the inhibitors of the enzyme may lead to novel skin whitening agents, anti-browning substances or compounds for insect control. A large numbers of moderate to potent tyrosinase inhibitors have been reported during the last decade. From our group, we reported a number of potent inhibitors from synthetic, semi-synthetic and natural origins. The compounds are from several chemical classes, like phenolics, terpenes, steroids, chalcones, flavonoids, alkaloids, long-chain fatty acids, coumarins, sildenafil analogs, bipiperidines, biscoumarins, oxadiazole, tetraketones, etc. More recently, the crystal structure of mushroom and couple of other tyrosinases has been published and more recently the crystal structure of mushroom tyrosinase complexes with a highly potent inhibitor tropolone has been reported. Yet there is a lack of information of inhibitor-tyrosinase intermolecular interactions. To overcome such issues, some researchers started utilizing in silico tools, like molecular docking simulations, for such purposes. There are also few papers published about the successful utilization of computational tools like QSAR-based and ligand-based virtual screening to identify novel and potent inhibitors of the enzyme. In our group, we are using all possible computational tools, like ligand-based as well structure-based approaches, to identify new inhibitors. In this review, some of such examples are briefly described.
Export Options
About this article
Cite this article as:
M.T.H. Khan , Novel Tyrosinase Inhibitors From Natural Resources – Their Computational Studies, Current Medicinal Chemistry 2012; 19 (14) . https://dx.doi.org/10.2174/092986712800229041
DOI https://dx.doi.org/10.2174/092986712800229041 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
Current advances in inherited cardiomyopathy
Describe in detail all novel advances in multimodality imaging related to inherited cardiomyopathy diagnosis and prognosis. Shed light to deeper phenotypic characterization. Acknowledge recent advances in genetics, genomics and precision medicineread more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Drug Delivery Systems for Prevention and Treatment of Osteoporotic Fracture
Current Drug Targets CD26/Dipeptidyl Peptidase IV as a Novel Therapeutic Target for Cancer and Immune Disorders
Mini-Reviews in Medicinal Chemistry Liposomal Formulation of Monovalent Cholesteryl Cytofectins with Acyclic Head Groups and Gene Delivery: A Systematic Review
Current Pharmaceutical Biotechnology The Minority Aging Research Study: Ongoing Efforts to Obtain Brain Donation in African Americans without Dementia
Current Alzheimer Research State of the Art of the Therapeutic Perspective of Sorafenib Against Hematological Malignancies
Current Medicinal Chemistry Genotoxicity of Nanocarriers
Current Drug Metabolism Copper Compounds in Anticancer Strategies
Current Medicinal Chemistry Amino Acid Transporter-Targeted Radiotracers for Molecular Imaging in Oncology
Current Medicinal Chemistry The Expanding Role of APRIL in Cancer and Immunity
Current Molecular Medicine Cellular Uptake of Cell-Penetrating Peptides
Drug Design Reviews - Online (Discontinued) New Anti-Mitotic Drugs with Distinct Anti-Calmodulin Activity
Mini-Reviews in Medicinal Chemistry α7 Nicotinic Acetylcholine Receptor Subunit in Angiogenesis and Epithelial to Mesenchymal Transition
Current Drug Targets Drug Delivery Systems Using Immobilized Intact Liposomes: A Comparative and Critical Review
Current Drug Delivery Nanoparticulate Iron Oxide Contrast Agents for Untargeted and Targeted Cardiovascular Magnetic Resonance Imaging
Current Nanoscience Ovarian Cancer Biomarkers: A Focus on Genomic and Proteomic Findings
Current Genomics Aromatase, Estrogens and Testicular Germ Cell Development
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Effects of Iron Chelation in Osteosarcoma
Current Cancer Drug Targets Naturally Occuring Pyrrolo[1,4]benzodiazepines in Bacteria
Mini-Reviews in Organic Chemistry Molecular Approaches Target to Immunotherapy for HPV-Associated Cancers
Current Cancer Drug Targets Peptimmunology: Immunogenic Peptides and Sequence Redundancy
Current Drug Discovery Technologies